All news

Nine planned sales by CEO-linked trusts at United Therapeutics (UTHR) total 1,960 shares.

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Family trusts associated with Martine A. Rothblatt, Chairperson and CEO of United Therapeutics (UTHR), sold a total of 1,960 common shares across nine transactions on November 5, 2026. These sales were executed as part of a pre-arranged Rule 10b5-1 trading plan adopted in November 2025. Following these transactions, Martine A. Rothblatt directly holds 40,513 common shares.

Read original source

UTHR company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.